[ad_1] Pharmaceutical firm Piramal Pharma Ltd on Tuesday (February 18) announced that the US FDA conducted a general GMP (Good Manufacturing Practice) inspection at its Turbhe, Navi Mumbai, facility between February 11-17, 2025. The inspection concluded with a Form 483 issued, containing six observations. Company Value Change %Change “This is to inform you that the […]